BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 8747719)

  • 1. Immunoregulatory effects of two bone-marrow hexapeptides (myelopeptides) in experimental models of immunodeficiency.
    Mikhailova AA; Shanurin SY; Petrov RV
    Immunol Lett; 1995 Sep; 47(3):199-203. PubMed ID: 8747719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Myelopeptide-1 blocks the T-suppressor activity.
    Petrov RV; Mikhailova AA; Kirilina EA
    Folia Biol (Praha); 1994; 40(6):455-61. PubMed ID: 7589703
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone marrow immunoregulatory peptides (myelopeptides): isolation, structure, and functional activity.
    Petrov RV; Mikhailova AA; Fonina LA
    Biopolymers; 1997; 43(2):139-46. PubMed ID: 9216250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Peculiarities of immunocorrective effects of the bone marrow regulatory peptides (myelopeptides).
    Mikhailova A; Fonina L; Kirilina E; Gur'yanov S; Efremov M; Petrov R
    Regul Pept; 2003 Jul; 114(2-3):183-7. PubMed ID: 12832108
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelopeptides: bone marrow regulatory mediators.
    Petrov RV; Mikhailova AA; Fonina LA
    Biosci Rep; 1995 Feb; 15(1):1-14. PubMed ID: 7647288
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The immunocorrective activity of myelopeptide-1 and myelopeptide-2 in cyclophosphane-treated mice].
    Shanurin SIu; Belevskaia RG; Mikhaĭlova AA; Shanurin MIu
    Eksp Klin Farmakol; 1995; 58(5):53-6. PubMed ID: 8704592
    [No Abstract]   [Full Text] [Related]  

  • 7. Immunoregulatory properties of hexapeptide isolated from porcine bone marrow cell culture.
    Mikhailova A; Fonina L; Kirilina E; Shanurin S; Gur'yanov S; Malakhov A; Nesmeyanov V; Petrov R
    Regul Pept; 1994 Oct; 53(3):203-9. PubMed ID: 7846296
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myelopeptides: new immunoregulatory peptides.
    Petrov R
    Allergy Proc; 1995; 16(4):177-84. PubMed ID: 8566725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Spatial structure of myelopeptides: I. Conformational analysis of MP-1, MP-2, and MP-3].
    Akhmetov NA; Ismailova LI; Abbasly RM; Akhmedov NF; Godzhaev NM
    Bioorg Khim; 2005; 31(1):31-8. PubMed ID: 15787211
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Endogenous immunoregulatory peptides (myelopeptides): structure, function, and mechanism of action].
    Petrov RV; Mikhaĭlova AA; Fonina LA
    Bioorg Khim; 1999 Nov; 25(11):811-5. PubMed ID: 10645485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The bone marrow peptide (myelopeptide-2) abolishes induced by human leukemia HL-60 cell suppression of T lymphocytes.
    Strelkov LA; Mikhailova AA; Sapozhnikov AM; Fonina LA; Petrov RV
    Immunol Lett; 1996 May; 50(3):143-7. PubMed ID: 8803611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Myelopeptide correction of the differentiation of hematopoietic precursor cells in mice with experimental T-immunodeficiency].
    Rudneva TB; Osipova EIu; Makhaĭlova AA; Man'ko VM
    Biull Eksp Biol Med; 1989 Jun; 107(6):718-20. PubMed ID: 2790172
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The nature of immunodeficiency induced by injections of lectins and cyclophosphamide].
    Kondrat'eva TK; Mikheeva NV; Fontalin LN
    Biull Eksp Biol Med; 1988 Aug; 106(8):195-8. PubMed ID: 3261998
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regulation by myelopid of immunoglobulin production in culture of human peripheral blood lymphocytes in normal and secondary immunodeficient state].
    Vlasenko RIa; Stepanenko RN; Koval'chuk LV
    Biull Eksp Biol Med; 1990 Aug; 110(8):180-2. PubMed ID: 2291967
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular basis of in vitro anti-DNA antibody production: evidence for T cell dependence of IgG-class anti-DNA antibody synthesis in the (NZB X NZW)F1 hybrid.
    Sekigawa I; Ishida Y; Hirose S; Sato H; Shirai T
    J Immunol; 1986 Feb; 136(4):1247-52. PubMed ID: 3484766
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunoregulatory properties of myelopeptide-1].
    Mikhaĭlova AA; Kirilina EA; Shanurin SIu; Fonina LA; Gur'ianov SA; Petrov RV
    Dokl Akad Nauk; 1994 Aug; 337(4):553-4. PubMed ID: 7951040
    [No Abstract]   [Full Text] [Related]  

  • 17. Ongoing immunologic activity after short courses of pulse cyclophosphamide in the NZB/W murine model of systemic lupus erythematosus.
    Austin HA; Patel AD; Cadena CA; Boumpas DT; Balow JE
    J Rheumatol; 1997 Jan; 24(1):61-8. PubMed ID: 9002012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Localization of spontaneously hyperactive B cells of NZB mice to a specific B cell subset.
    Nakajima PB; Datta SK; Schwartz RS; Huber BT
    Proc Natl Acad Sci U S A; 1979 Sep; 76(9):4613-6. PubMed ID: 315562
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The effect of bone marrow hexapeptides (myelopeptides) on antibody formation and pain sensitivity in mice and dependence of these effects on naloxone].
    Metaksa EE; Zakharova LA; Koptelov OV; Koroleva NA; Ianovskiĭ OG
    Biull Eksp Biol Med; 1995 Apr; 119(4):413-6. PubMed ID: 7620142
    [No Abstract]   [Full Text] [Related]  

  • 20. Participation by opioids in the immunostimulatory activity of myelopeptides.
    Zakharova LA; Belevskaya RG; Yanovskii OG
    Biomed Sci; 1990 Feb; 1(2):139-43. PubMed ID: 2102777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.